microdosing glp-1 medications definition Microdose Protocol Microdosing GLP-1: Understanding the Risks

H.Sinnett-SmithJ.et al (2017)

Phase 2 trials used up to 12 mg/week and produced 24.2% body weight loss at 48 weeks community protocols are deliberately more conservative

Another is by subjecting its products to trials, which Pendulum has also done, with good tolerability among participants

Research suggests that many people regain weight after discontinuing GLP-1 medications, which means you may need to continue treatment indefinitely to maintain weight loss

In fact, studies show that digestive enzymes can actually enhance the benefits of GLP-1s by improving nutrient absorption without interfering with delayed gastric emptying

It is currently the focus of ongoing non-clinical and preclinical studies that aim to better understand its role in signaling